Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAES transplantation in neonatal onset urea cycle disorder
jRCT1090220412Recruiting
- Sponsor
- National Center for Child Health and Development
- Start
- Feb 2019
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of hepatocyte-like cell therapy in urea cycle disorder (UCD), sponsored by National Center for Child Health and Development. Primary endpoint: Incidence and severity of adverse events and treatment failures. Started Feb 2019; status: recruiting.
02
Drugs
hepatocyte-like cell therapy
03
Conditions
urea cycle disorder (UCD)
Beyond the preview
Go deeper on jRCT1090220412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220412.